Rhabdomyolysis side effects
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Rhabdomyolysis Side Effects: An Overview
Introduction to Rhabdomyolysis
Rhabdomyolysis is a serious medical condition characterized by the breakdown of skeletal muscle tissue, leading to the release of muscle fiber contents into the bloodstream. This can range from a mild, asymptomatic condition to a severe, life-threatening illness. The primary clinical manifestations include muscle weakness, myalgia, and tea-colored urine, with elevated plasma creatine kinase (CK) levels being the most sensitive laboratory indicator of muscle injury.
Common Causes and Risk Factors
Muscular Trauma and Physical Exertion
Muscular trauma is the most common cause of rhabdomyolysis. Physical exertion, especially in individuals unaccustomed to intense exercise, can also trigger the condition. For instance, a case of localized rhabdomyolysis was reported in a cardiac transplant recipient following physical exertion while on statin therapy.
Drug-Induced Rhabdomyolysis
Several medications are known to induce rhabdomyolysis. Statins, commonly used to manage hyperlipidemia, are a well-recognized cause. The risk increases when statins are combined with other drugs, such as ciprofloxacin, which has been shown to cause rhabdomyolysis and acute kidney injury (AKI) in a mouse model. Other drugs, including levetiracetam and trimethoprim-sulfamethoxazole, have also been implicated in rare cases .
Infections and Vaccinations
Infections, particularly viral infections like influenza, can lead to rhabdomyolysis. There have been rare instances where the influenza A H1N1 vaccine has induced rhabdomyolysis, especially in patients concurrently using statins. Additionally, COVID-19 has emerged as a recent contributor to rhabdomyolysis, highlighting the need for vigilance in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Complications of Rhabdomyolysis
Acute Kidney Injury (AKI)
One of the most severe complications of rhabdomyolysis is AKI, which occurs due to the toxic effects of myoglobin on the kidneys. This can lead to renal vasoconstriction, ischemia, and myoglobin cast formation in the renal tubules. Studies have shown that a significant proportion of patients with severe rhabdomyolysis develop AKI, with some requiring renal replacement therapy (RRT).
Electrolyte Imbalances
Rhabdomyolysis can cause significant electrolyte disturbances, including hyperkalemia, which may lead to cardiac arrhythmias, metabolic acidosis, hyperphosphatemia, early hypocalcemia, and late hypercalcemia. These imbalances necessitate careful monitoring and management to prevent life-threatening complications.
Other Complications
Other potential complications include compartment syndrome, which requires monitoring of intra-compartmental pressure and possibly fasciotomy, and disseminated intravascular coagulation (DIC), a severe coagulopathy.
Management and Treatment
Early and Aggressive Hydration
The cornerstone of rhabdomyolysis management is early and aggressive fluid resuscitation to prevent AKI and promote the clearance of myoglobin from the kidneys. Urine alkalinization with sodium bicarbonate and the use of diuretics like mannitol or furosemide have been suggested, although their benefits remain unproven.
Monitoring and Supportive Care
Patients with severe rhabdomyolysis require close monitoring of renal function and electrolytes. In cases of severe AKI or life-threatening hyperkalemia, hemodialysis may be necessary. Additionally, addressing the underlying cause, such as discontinuing the offending drug, is crucial for recovery.
Conclusion
Rhabdomyolysis is a multifaceted condition with a wide range of causes and potential complications. Early recognition and prompt treatment are essential to prevent severe outcomes, particularly AKI. Clinicians must be aware of the various risk factors, including drug interactions and infections, to manage and mitigate the side effects effectively.
Sources and full results
Most relevant research papers on this topic